Atrial fibrillation patients saw 69% lower risk with common blood thinners

According to the randomized SINGLE-AF trial, direct oral anticoagulants cut the risk of serious clinical events by 69% in atrial fibrillation patients with an intermediate risk of stroke. The reported benefit was driven mainly by fewer ischemic strokes, with no increase in major bleeding.

Headlines are indexed or machine translated, not independent verification of scientific results. Medical news is not clinical advice. Distinguish interstellar concepts from demonstrated space technology using the original source.